NovoCure NVCR
NASDAQ NVCR
$15.92 -0.03 (-0.19%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovoCure (NVCR) Cash from Financing Activities (2014 - 2026)

Updated

NovoCure (NVCR) posted Cash from Financing Activities of $4.55 million for Q2 2026, up 90.5% from $2.39 million a year earlier.

Analysis

NovoCure (NVCR) Cash from Financing Activities (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at NovoCure was -$454.6 million; for FY2025, it came in at -$451.34 million.

  • In prior years, NovoCure's Cash from Financing Activities was $90.32 million in FY2024 (+472.1%), $15.79 million in FY2023 (+1.9%), $15.49 million in FY2022 (-39.7%) and $25.7 million in FY2021 (-94.2%).
  • Quarterly Cash from Financing Activities has run from a low of -$559.49 million in Q4 2025 to a high of $100.52 million in Q3 2025 over five years.
  • On a year-over-year basis, Cash from Financing Activities increased in two of the last four quarters, with an average decline of 14.4%.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q2 2026, with growth of 90.5%; the weakest was Q4 2021, with a decline of 99.4%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was -$166,000 (Q1 2026), -$559.49 million (Q4 2025) and $100.52 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -1.57 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -3.52 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 7.27 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -287.90 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -343.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -95.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -410.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -300,000.00
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -577.00 Mn
10 NovoCure 1.86 Bn -496.48 Mn 142.48 Mn 4.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.55 Mn
Mar 31, 2026 -166,000.00
Dec 31, 2025 -559.49 Mn
Sep 30, 2025 100.52 Mn
Jun 30, 2025 2.39 Mn
Mar 31, 2025 5.25 Mn
Dec 31, 2024 2.69 Mn
Sep 30, 2024 100,000.00
Jun 30, 2024 87.32 Mn
Mar 31, 2024 213,000.00
Dec 31, 2023 1.91 Mn
Sep 30, 2023 1.17 Mn
Jun 30, 2023 7.50 Mn
Mar 31, 2023 5.20 Mn
Dec 31, 2022 3.41 Mn
Sep 30, 2022 4.20 Mn
Jun 30, 2022 4.74 Mn
Mar 31, 2022 3.14 Mn
Dec 31, 2021 3.65 Mn
Sep 30, 2021 3.04 Mn
API Access

NovoCure Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NVCR&period=max&api_key=YOUR_API_KEY